Literature DB >> 18338859

Pores formation on cell membranes by hederacolchiside A1 leads to a rapid release of proteins for cytosolic subproteome analysis.

Gabriel D Mazzucchelli1, Nicolas A Cellier, Vakhtang Mshviladzade, Riad Elias, Yong-Ho Shim, David Touboul, Loïc Quinton, Alain Brunelle, Olivier Laprévote, Edwin A De Pauw, Marie-Claire A De Pauw-Gillet.   

Abstract

Hederacolchiside A1 was used to progressively permeabilize the membrane of human melanoma MEL-5 cells. Holes formation was followed by Scanning Electron Microscopy and interaction of the saponin with cholesterol and phospholipids by TOF-SIMS. 2D-LC-MS/MS and 2D-SDS-PAGE show that the release of soluble proteins into serum-free culture media increases with time. This can lead to a new rapid and efficient strategy to analyze the cytosolic subproteome and it opens the door to get information from the cytosolic compartment for clinical proteomic studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338859     DOI: 10.1021/pr7006973

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  3 in total

Review 1.  Multiplexed strategies toward clinical translation of extracellular vesicles.

Authors:  Junying Song; Baoqiang Song; Lijun Yuan; Guodong Yang
Journal:  Theranostics       Date:  2022-09-21       Impact factor: 11.600

2.  Analysis of the immune response of human dendritic cells to Mycobacterium tuberculosis by quantitative proteomics.

Authors:  Chiu-Ping Kuo; Kuo-Song Chang; Jue-Liang Hsu; I-Fang Tsai; Andrew Boyd Lin; Tsai-Yin Wei; Chien-Liang Wu; Yen-Ta Lu
Journal:  Proteome Sci       Date:  2016-03-08       Impact factor: 2.480

3.  Micelles self-assembled by 3-O-β-D-glucopyranosyl latycodigenin enhance cell membrane permeability, promote antibiotic pulmonary targeting and improve anti-infective efficacy.

Authors:  Man Zhang; Lili Ye; Hao Huang; Dandan Cheng; Kaixin Liu; Wenbo Wu; Fukui Shen; Zhihong Jiang; Yuanyuan Hou; Gang Bai
Journal:  J Nanobiotechnology       Date:  2020-10-02       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.